Rocket Lab Corp

Rocket Lab Corp (RKLB) News & Events

$63.810

+0.721 (+1.13%)At close

RKLB News

RKLB Events

9/3 14:30

Rocket Lab USA Shares Rise 0.7% to $63.54

Cboe data suggests bullish flow in Rocket Lab USA (RKLB), with shares up 44c, or 0.7%, near $63.54. Options volume roughly in line with average with 96k contracts traded and calls leading puts for a put/call ratio of 0.21, compared to a typical level near 0.5. Implied volatility (IV30) is higher by 0.3 points near 64.94,in the lowest 10% of observations over the past year, suggesting an expected daily move of $2.60. Put-call skew flattened, suggesting a modestly bullish tone.

8/17 08:30

Viasat Announces New Partnership

Viasat (VSAT) announced…

8/13 09:30

Rocket Lab's Antitrust Waiting Period for Iridium Acquisition Expired

Rocket Lab (RKLB) announced that the waiting period under the U.S. Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with its pending acquisition of Iridium (IRDM) expired at 11:59 p.m., Eastern Time, on August 12. Rocket Lab also filed its statement on Form S-4 with the SEC related to the Iridium acquisition to register the Rocket Lab securities to be delivered to Iridium shareholders to satisfy the equity consideration at the closing of the transaction. The registration statement has not yet become effective, and the securities described in it may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. Rocket Lab further announced that on August 10, Rocket Lab and Iridium filed with the Federal Communications Commission applications seeking its consent to transfer control of Iridium's licenses and authorizations to Rocket Lab. As part of its financing strategy, Rocket Lab announced today that, together with Iridium, it intends to seek certain amendments to Iridium's existing term loan credit facility with an aggregate amount of $1.78B outstanding as of June 30, which would allow the Iridium facility to remain in place following Rocket Lab's acquisition, and which would reduce the company's debt commitments correspondingly at much more attractive rates than the bridge facility terms. Such amendments, if completed, will require the consent of lenders under Iridium's facility, and there is no assurance at this time that the Company will obtain such consents.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started